Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other Non-Current Liabilities (2017 - 2025)

Historic Other Non-Current Liabilities for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $2.5 million.

  • Organogenesis Holdings' Other Non-Current Liabilities rose 9389.49% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 9389.49%. This contributed to the annual value of $894000.0 for FY2024, which is 2629.84% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Other Non-Current Liabilities stood at $2.5 million, which was up 9389.49% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Other Non-Current Liabilities registered a high of $8.7 million during Q2 2021, and its lowest value of $894000.0 during Q4 2024.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $1.2 million (2023), whereas its average is $2.2 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Other Non-Current Liabilities plummeted by 8761.97% in 2022, and later surged by 13832.81% in 2025.
  • Organogenesis Holdings' Other Non-Current Liabilities (Quarter) stood at $1.6 million in 2021, then fell by 27.94% to $1.1 million in 2022, then increased by 8.11% to $1.2 million in 2023, then fell by 26.3% to $894000.0 in 2024, then surged by 180.65% to $2.5 million in 2025.
  • Its Other Non-Current Liabilities stands at $2.5 million for Q3 2025, versus $3.0 million for Q2 2025 and $897000.0 for Q1 2025.